Clinical Trials Directory

Trials / Completed

CompletedNCT03297164

Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment

One Year Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment-A Prospective,Multicenter,Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
12,043 (actual)
Sponsor
Harbin Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to build a multi-center, prospective and regionally representative acute myocardial infarction(AMI) cohort,and build a study platform for heart failure caused by AMI; To explore the 1 year incidence rate of heart failure after AMI given the optimized treatment and the treatment model affecting the incidence rate of heart failure, and finally to reduce the incidence rate of heart failure by 5%.

Detailed description

the study aim to enroll 12000 acute myocardial infartion (AMI) patients, including ST-segment elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction (NSETMI), Patients were divided into two groups(optimized group and un-optimized group) according to treatment models they accepted in 20 reginally representative hosptials of China. whether optimizaed or not is judged by 4 four aspects,including emergency treatment procedure, pre-infusion medication, reperfusion strategy selection, and early rehabilitation after reperfusion.Patients were followed at 1 month, 6 months and 12 months. The physical condition and clinical events(heart failure, death, re-infarction, revascularization, apoplexy, malignant arrhythmias, bleeding events, other adverse events)were collected at follow up.

Conditions

Timeline

Start date
2017-12-21
Primary completion
2020-12-04
Completion
2021-06-30
First posted
2017-09-29
Last updated
2021-10-01

Locations

19 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03297164. Inclusion in this directory is not an endorsement.